You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Beverly pharmaceutical company claims it’s at leading edge of research on new cancer drug

Beverly biopharmaceutical company Cellceutix Corp. on Monday said a cancer drug it is testing in clinical trials is more advanced than similar treatments under development by larger companies that featured in The New York Times Sunday.

Merck & Co., Roche Holding Ltd. and Sanofi SA are working on cancer drugs that would enable a protein called p53 to perform its normal function -- causing badly damaged cells to self-destruct. Cancer cells disable p53, allowing them to multiply, but the drugs would reactivate the protein and kill cancer cells.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week